VisionCare Ophthalmic Technologies, Inc.: Series E $31M

Posted in I - Series E, Q - 1Q11, R - WEST, X - AMD, X - Device (Ophthalmology), XX - CA

VisionCare Ophthalmic Technologies (Saratoga, CA) a commercial-stage medical device company focused on advanced age-related macular degeneration, closed a $31M Series E financing. Participants include Saints Venture Capital, Giza Ventures, Generali Financial Holdings, BSI, Pitango Venture Capital, Three Arch Partners, Onset Ventures and Infinity CSVC Management.

Nov

2008

Potentia Pharmaceuticals, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q08, R - SOUTH EAST, X - AMD, X - Inflammation

Potentia Pharmaceuticals (Louisville, KY) development-stage biotechnology company focused on therapeutics for chronic inflammatory diseases, closed a $12M Series B financing. Participants include HealthCare Ventures and MASA Life Science Ventures.

Apr

2008

Taligen Therapeutics, Inc.: Series B $65M

Posted in I - Series B, Q - 1Q08, R - ROCKY MOUNTAIN, X - AMD, X - Asthma, X - Inflammation

Taligen Therapeutics (Aurora, CO) a development stage biotechnology company focused on the treatment of serious inflammatory diseases including asthma, macular degeneration and immune kidney disease closed a $65M Series B financing. Participants include Alta Partners, Clarus Ventures, Sanderling Ventures, Tango and High Country Venture.

to top of page...